๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck

โœ Scribed by Robert Haddad; Lori Wirth; Rosemary Costello; Linda Weeks; Marshall Posner

Book ID
114473403
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
75 KB
Volume
30
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Randomized phase 2 study of concomitant
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer
โœ Robert Haddad; Stephen Sonis; Marshall Posner; Lori Wirth; Rosemary Costello; Pa ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 272 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND: A randomized phase 2 study was performed to investigate the efficacy/toxicity of combining concomitant boost radiation and weekly carboplatin/paclitaxel with or without amifostine in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). ##

Phase II study of induction chemotherapy
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck
โœ Dong M. Shin; Bonnie S. Glisson; Fadlo R. Khuri; Scott M. Lippman; Lawrence Gins ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND This Phase II trial was conducted to determine the response rate, particularly of the primary sites, tolerability, and toxicity of induction chemotherapy of paclitaxel, ifosfamide, and carboplatin for patients with previously untreated locally advanced squamous cell carci